Login
Home
Charts
Search
Watchlist
Products

Chamanlal Setia Exports Ltd

CLSEL·NSE
293.40+0.05%Tue, 22 Sept '26

Chamanlal Setia Exports Ltd

CLSEL
NSE
293.40
+0.05%
|Tue, 22 Sept '26
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
1,459Cr
Close
Close Price
293.40
Industry
Industry
FMCG - Rice
PE
Price To Earnings
11.65
PS
Price To Sales
0.99
Revenue
Revenue
1,478Cr
Rev Gr TTM
Revenue Growth TTM
2.68%
PAT Gr TTM
PAT Growth TTM
22.80%

Quarterly Results

Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
309400384363369395368307273431428346
Growth YoY
Revenue Growth YoY%
15.813.17.437.819.7-1.2-4.1-15.3-26.19.016.512.6
Expenses
ExpensesCr
273348348331333356334278249380376302
Operating Profit
Operating ProfitCr
365236323640332924515244
OPM
OPM%
11.513.09.38.99.810.09.19.68.911.812.112.6
Other Income
Other IncomeCr
242223224142
Interest Expense
Interest ExpenseCr
134212522232
Depreciation
DepreciationCr
122112-111111
PBT
PBTCr
355231303639322925485243
Tax
TaxCr
91388910776121311
PAT
PATCr
263923232729252219363832
Growth YoY
PAT Growth YoY%
29.93.3-38.4-17.71.8-25.05.6-4.3-29.123.955.947.8
NPM
NPM%
8.59.76.16.27.27.36.77.06.98.38.99.3
EPS
EPS
5.17.54.54.45.55.84.94.33.87.27.76.4
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
309400384363369395368307273431428346
Growth YoY
Revenue Growth YoY%
15.813.17.437.819.7-1.2-4.1-15.3-26.19.016.512.6
Expenses
ExpensesCr
273348348331333356334278249380376302
Operating Profit
Operating ProfitCr
365236323640332924515244
OPM
OPM%
11.513.09.38.99.810.09.19.68.911.812.112.6
Other Income
Other IncomeCr
242223224142
Interest Expense
Interest ExpenseCr
134212522232
Depreciation
DepreciationCr
122112-111111
PBT
PBTCr
355231303639322925485243
Tax
TaxCr
91388910776121311
PAT
PATCr
263923232729252219363832
Growth YoY
PAT Growth YoY%
29.93.3-38.4-17.71.8-25.05.6-4.3-29.123.955.947.8
NPM
NPM%
8.59.76.16.27.27.36.77.06.98.38.99.3
EPS
EPS
5.17.54.54.45.55.84.94.33.87.27.76.4

Profit & Loss

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
4834937477657988519321,3871,3561,4951,4401,478
Growth
Revenue Growth%
-5.02.251.32.54.36.79.548.8-2.310.3-3.72.7
Expenses
ExpensesCr
4244296777027197348371,2281,1941,3541,2831,307
Operating Profit
Operating ProfitCr
596570637911895159162141157171
OPM
OPM%
12.113.19.48.29.913.810.211.411.99.410.911.6
Other Income
Other IncomeCr
5322334111091111
Interest Expense
Interest ExpenseCr
45877677101099
Depreciation
DepreciationCr
344455567455
PBT
PBTCr
575860537011087157155136154168
Tax
TaxCr
202018181828224039333943
PAT
PATCr
37394234528265118116103115125
Growth
PAT Growth%
91.03.58.0-17.452.556.3-20.881.1-1.7-11.011.622.8
NPM
NPM%
7.77.85.64.56.69.67.08.58.56.98.08.5
EPS
EPS
7.27.48.16.710.215.912.622.822.420.723.125.2
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
4834937477657988519321,3871,3561,4951,4401,478
Growth
Revenue Growth%
-5.02.251.32.54.36.79.548.8-2.310.3-3.72.7
Expenses
ExpensesCr
4244296777027197348371,2281,1941,3541,2831,307
Operating Profit
Operating ProfitCr
596570637911895159162141157171
OPM
OPM%
12.113.19.48.29.913.810.211.411.99.410.911.6
Other Income
Other IncomeCr
5322334111091111
Interest Expense
Interest ExpenseCr
45877677101099
Depreciation
DepreciationCr
344455567455
PBT
PBTCr
575860537011087157155136154168
Tax
TaxCr
202018181828224039333943
PAT
PATCr
37394234528265118116103115125
Growth
PAT Growth%
91.03.58.0-17.452.556.3-20.881.1-1.7-11.011.622.8
NPM
NPM%
7.77.85.64.56.69.67.08.58.56.98.08.5
EPS
EPS
7.27.48.16.710.215.912.622.822.420.723.125.2

Balance Sheet

Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
910101010101010101010
Reserves
ReservesCr
101137184215263339399598704723828
Current Liabilities
Current LiabilitiesCr
5472102124102111154158223171126
Non Current Liabilities
Non Current LiabilitiesCr
1833374749585751586376
Total Liabilities
Total LiabilitiesCr
1832523333964245196218189949681,040
Current Assets
Current AssetsCr
160228303365377466562676846805872
Non Current Assets
Non Current AssetsCr
23243131475359142149162168
Total Assets
Total AssetsCr
1832523333964245196218189949681,040
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
910101010101010101010
Reserves
ReservesCr
101137184215263339399598704723828
Current Liabilities
Current LiabilitiesCr
5472102124102111154158223171126
Non Current Liabilities
Non Current LiabilitiesCr
1833374749585751586376
Total Liabilities
Total LiabilitiesCr
1832523333964245196218189949681,040
Current Assets
Current AssetsCr
160228303365377466562676846805872
Non Current Assets
Non Current AssetsCr
23243131475359142149162168
Total Assets
Total AssetsCr
1832523333964245196218189949681,040

Cash Flow

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
63-17-49-225137-587-387351
Investing Cash Flow
Investing Cash FlowCr
1-3-10-5-19-8-7-4-6-11-2
Financing Cash Flow
Financing Cash FlowCr
-25192226-332215-445-62-49
Net Cash Flow
Net Cash FlowCr
39-1-37-1051-50-1000
Free Cash Flow
Free Cash FlowCr
66-23-60-273026-69-2-525541
CFO To PAT
CFO To PAT%
170.1-43.9-117.8-62.697.145.6-89.86.1-33.070.744.6
CFO To EBITDA
CFO To EBITDA%
108.2-26.2-70.1-34.564.531.7-61.34.5-23.651.532.6
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
63-17-49-225137-587-387351
Investing Cash Flow
Investing Cash FlowCr
1-3-10-5-19-8-7-4-6-11-2
Financing Cash Flow
Financing Cash FlowCr
-25192226-332215-445-62-49
Net Cash Flow
Net Cash FlowCr
39-1-37-1051-50-1000
Free Cash Flow
Free Cash FlowCr
66-23-60-273026-69-2-525541
CFO To PAT
CFO To PAT%
170.1-43.9-117.8-62.697.145.6-89.86.1-33.070.744.6
CFO To EBITDA
CFO To EBITDA%
108.2-26.2-70.1-34.564.531.7-61.34.5-23.651.532.6

Ratios

Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2875427204361784455078891,0541,5451,0251,459
Price To Earnings
Price To Earnings
7.714.117.312.73.45.47.87.69.115.08.911.7
Price To Sales
Price To Sales
0.61.11.00.60.20.50.50.60.81.00.71.0
Price To Book
Price To Book
2.63.73.71.90.71.31.21.71.72.41.41.9
EV To EBITDA
EV To EBITDA
4.58.311.28.62.94.06.56.17.211.46.28.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
22.224.117.817.119.624.725.422.821.420.922.022.0
OPM
OPM%
12.113.19.48.29.913.810.211.411.99.410.911.6
NPM
NPM%
7.77.85.64.56.69.67.08.58.56.98.08.5
ROCE
ROCE%
45.132.925.318.222.526.117.822.618.517.117.717.7
ROE
ROE%
33.826.121.415.319.223.515.919.316.214.013.713.7
ROA
ROA%
20.415.312.58.712.415.810.514.411.610.611.011.0
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
2875427204361784455078891,0541,5451,0251,459
Price To Earnings
Price To Earnings
7.714.117.312.73.45.47.87.69.115.08.911.7
Price To Sales
Price To Sales
0.61.11.00.60.20.50.50.60.81.00.71.0
Price To Book
Price To Book
2.63.73.71.90.71.31.21.71.72.41.41.9
EV To EBITDA
EV To EBITDA
4.58.311.28.62.94.06.56.17.211.46.28.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
22.224.117.817.119.624.725.422.821.420.922.022.0
OPM
OPM%
12.113.19.48.29.913.810.211.411.99.410.911.6
NPM
NPM%
7.77.85.64.56.69.67.08.58.56.98.08.5
ROCE
ROCE%
45.132.925.318.222.526.117.822.618.517.117.717.7
ROE
ROE%
33.826.121.415.319.223.515.919.316.214.013.713.7
ROA
ROA%
20.415.312.58.712.415.810.514.411.610.611.011.0
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
- **Chamanlal Setia Exports is the world’s largest private-label basmati rice trader - a farm-to-fork operation that mills, packs and ships rice to over 95 countries, with its corporate office in Gurgaon and manufacturing plant in Karnal, Haryana**. Founded in 1974 as a single rice mill and exporting since 1982, the company has grown into a fully integrated processor with a deliberately simple playbook: buy paddy for cash at a discount, process it fast without ageing inventory, and sell to loyal private-label customers who value consistent quality over chasing the lowest price. That approach - asset-light, debt-free by year-end, and allergic to speculative or high-risk markets - has kept the business standing through four decades of commodity cycles. # Business segments A single engine - basmati rice milling, packing and export - that runs on two revenue streams: private-label manufacturing for overseas retailers, and a smaller but growing own-brand business sold across India and 40-plus countries. ## 1. Basmati rice: the world’s private-label kitchen **The company makes rice for other people’s brands - over 300 of them - and that is a harder business than it looks, because private-label customers demand flawless consistency and will stay for decades once they get it.** - **Paid per tonne, shipped on its own terms** - revenue comes from selling rice by the metric tonne, mostly on a CIF basis (the company arranges and prices the ocean freight itself) so it controls the shipment until delivery and avoids destination risk. Exports contribute roughly 88% of revenue, with the balance from domestic Indian sales. - **Bought for cash, at a discount** - the company pays paddy suppliers within three to four days to capture a 2% cash discount, and its long-standing relationships with commission agents across Haryana and Punjab mandis let it procure year-round at comfortable prices. That quick payment cycle is the first link in a working-capital chain that resets every year: inventory builds after the October-November harvest, then liquidates as sales convert to cash and debt is paid down. - **Processed fast, not aged** - unlike rivals who tie up capital ageing rice for months, the company buys semi-finished rice and runs it through Sortex machines to finished grade, keeping the processing cycle short and inventory risk low. Its 16 Sortex machines across Karnal and Mundra can handle 880 metric tonnes a day, supported by 19 dryers and 82,500 metric tonnes of warehouse space. - **The moat is the customer relationship** - the company has 440-plus distributors globally with an average relationship of about 15 years, and a buyer base of more than 900 across 90-plus countries. Private-label buyers, once satisfied with quality and consistency, rarely switch even though they could - and the company deliberately avoids very large wholesale orders in favour of a mix of large and small customers, which keeps bargaining power balanced. - **Risk is avoided by design** - the company will not sell to Iran on credit and ships there only when a Dubai intermediary pays fully in advance; it limits exposure in Iraq where profitability is thin; and all exports are insured through India’s Export Credit Guarantee Corporation. The guiding principle is never to enter a market where it could get trapped. ## 2. Own brands: the small but growing shop window **Maharani, the flagship brand launched in 1980, is now on shelves in over 40 countries - still a modest slice of revenue, but the part of the business that puts the company’s name, not a retailer’s, in front of the consumer.** - **A brand built over four decades** - “Maharani Basmati Rice” was trademarked in 1980 and has since been joined by “Mithas” and “Begum” in basmati, plus “Green World Aromatic Rice” in non-basmati. Own-brand sales were about 10% of total revenue in FY24, with the Maharani brand alone growing 46% that year. - **Differentiated products for health-conscious buyers** - the portfolio includes Maharani Diabetics Rice (certified low-glycaemic, launched in 2018), Brown Basmati Rice, and quick-cooking brown rice, all of which doubled revenues in FY24 from a small base. The company also sells Sella, Bhatti Sella, smoked rice and pesticide-residue-free rice under its own labels. - **Domestic distribution is the next frontier** - the company is strengthening its Maharani distribution network across major Indian cities, building on a Pan-India presence that already spans more than 90 countries globally. # Group structure and partners **A family-run, debt-averse exporter with no subsidiaries and a tightly held promoter stake - the structure is as simple as the business model.** - The company has no subsidiaries, holding companies, associate companies or joint ventures; it is a single listed entity on both BSE and NSE. - Promoters held roughly 74% of shares as of FY20, with a free float of about 26% in FY24. - Key management is drawn entirely from the Setia family: Mr. Vijay Kumar Setia (Chairman & Managing Director, and president of the All India Rice Exporters Association), Mr. Rajeev Setia (Joint MD & CFO), and three Whole Time Directors from the next generation - Ankit, Sankesh and Shweta Setia. - The company employs 198 permanent staff as of March 2025, including a research associate with a Ph.D. in food science, and runs its own in-house R&D that has delivered patented parboiling processes, a pesticide-reduction technique, and a solar plant at the Karnal unit.

Documents — Chamanlal Setia Exports Ltd

  • Q1 FY2027 Earnings Call Transcript (Jun 2026, PDF): https://www.stockscans.in/document/mwg1agj4kalixab28h7yt85r.pdf
  • Q4 FY2026 Earnings Call Transcript (Mar 2026, PDF): https://www.stockscans.in/document/f83itywppf66suqax8783n6m.pdf
  • Q3 FY2026 Earnings Call Transcript (Dec 2025, PDF): https://www.stockscans.in/document/dy27qpj3fxajx6pcw3t6l41z.pdf
  • Q2 FY2026 Earnings Call Transcript (Sep 2025, PDF): https://www.stockscans.in/document/40jvt99v5uoxequtg92ob50c.pdf
  • Q1 FY2026 Earnings Call Transcript (Jun 2025, PDF): https://www.stockscans.in/document/cqnevav1bzxrt6h03r3cengr.pdf
  • Q4 FY2025 Earnings Call Transcript (Mar 2025, PDF): https://www.stockscans.in/document/7ix2etwe1j4ys7luxqh4sp2v.pdf
  • Q3 FY2025 Earnings Call Transcript (Dec 2024, PDF): https://www.stockscans.in/document/ydbp4pvi4au6npn07ioit9i5.pdf
  • Q2 FY2025 Earnings Call Transcript (Sep 2024, PDF): https://www.stockscans.in/document/irp3xm9gj8qlmt48kq4y4cwc.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/rx5ipya618395aurd4529lkn.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/cfrw3c8vkqotc8884ncx97ap.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/97pos28x3jkb1i092navkiqk.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/13z8m6ccuibx50gtawdhj0uc.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/8mn13skc5ckqggafjitbhrue.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/vv4n18w5s37uwlb10fca6dqt.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/rni0320s0di29zat0cbi7jyt.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/zjj21uaooaoky8hxc8hu9alu.pdf
  • Q1 FY2027 Investor Presentation (Jun 2026, PDF): https://www.stockscans.in/document/ye6c2834xh0mx7j5zmh44sta.pdf
  • Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/d782020cgn8q6j9werzz1htz.pdf
  • Q3 FY2026 Investor Presentation (Dec 2025, PDF): https://www.stockscans.in/document/pvrlpj2ybtxzm6lmsevsyb4u.pdf
  • Q2 FY2026 Investor Presentation (Sep 2025, PDF): https://www.stockscans.in/document/g2qlkw167j6odmmef094ci7s.pdf
  • Q1 FY2026 Investor Presentation (Jun 2025, PDF): https://www.stockscans.in/document/9t4ml6fs1w44iqli9xrvq01v.pdf
  • Q4 FY2025 Investor Presentation (Mar 2025, PDF): https://www.stockscans.in/document/u8txmqsuwojgcczcjmdymcte.pdf
  • Q3 FY2025 Investor Presentation (Dec 2024, PDF): https://www.stockscans.in/document/olpl7j6hr1ehq4brune0zgln.pdf
  • Q2 FY2025 Investor Presentation (Sep 2024, PDF): https://www.stockscans.in/document/4pyicgtcjv25g8dc59gf71en.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/ny4njgtsdseosfg9eq9ovvfc.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/zbz93jilekd4tknkxfnsodxi.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/c48iqb5gicpgxegax9f3d98v.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/c8ivmeg8exolowrjod9xdhkf.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/iqk5663z2pv95agwg078a0ux.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/ppc35dv56b1v8byanomt1dk5.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/o3n7otl00gy173x39pzs0bmq.pdf

Concall Transcript Summaries — Chamanlal Setia Exports Ltd

  • Q1 FY2027 Concall Transcript Summary (Jun 2026): https://www.stockscans.in/company/NSE%3ACLSEL/transcript-notes/202606/mwg1agj4kalixab28h7yt85r.pdf
  • Q4 FY2026 Concall Transcript Summary (Mar 2026): https://www.stockscans.in/company/NSE%3ACLSEL/transcript-notes/202603/f83itywppf66suqax8783n6m.pdf
  • Q3 FY2026 Concall Transcript Summary (Dec 2025): https://www.stockscans.in/company/NSE%3ACLSEL/transcript-notes/202512/dy27qpj3fxajx6pcw3t6l41z.pdf
  • Q2 FY2026 Concall Transcript Summary (Sep 2025): https://www.stockscans.in/company/NSE%3ACLSEL/transcript-notes/202509/40jvt99v5uoxequtg92ob50c.pdf
  • Q1 FY2026 Concall Transcript Summary (Jun 2025): https://www.stockscans.in/company/NSE%3ACLSEL/transcript-notes/202506/cqnevav1bzxrt6h03r3cengr.pdf
  • Q4 FY2025 Concall Transcript Summary (Mar 2025): https://www.stockscans.in/company/NSE%3ACLSEL/transcript-notes/202503/7ix2etwe1j4ys7luxqh4sp2v.pdf
  • Q3 FY2025 Concall Transcript Summary (Dec 2024): https://www.stockscans.in/company/NSE%3ACLSEL/transcript-notes/202412/ydbp4pvi4au6npn07ioit9i5.pdf
  • Q2 FY2025 Concall Transcript Summary (Sep 2024): https://www.stockscans.in/company/NSE%3ACLSEL/transcript-notes/202409/irp3xm9gj8qlmt48kq4y4cwc.pdf